Business
The company will use the funds to support its ongoing clinical trial, ramp up production and sales for its OtoSight Middle Ear Scope and relocate its headquarters.
The company will use the funds to try and level the playing field between payers and providers.
The funds will be used to strengthen the company's platform with AI-driven features, increase its product development and meet rising market demand for digital healthcare.
The money will be used to develop new medications and biologicals.
OneCell Diagnostics scores $16 million for genomics-based precision oncology and dannce.ai, a phenotyping platform to digitize clinical assessments, secures $2.6 million.
Also, an Indian startup has raised $1 million in seed funding to develop dental nanorobots.
The funds will be used to enhance its technology, expand its partnership with payers and providers, scale its reach and accelerate clinical research through enrollment support.
The company will use the funds to support people who are managing rare and complex conditions.
Vitality will integrate WellSpark's coaching tools to enhance the services it offers employers and health plans.
The women's healthcare company failed to find adequate product market fit, and the company's CEO, Alison Greenberg, says many lessons were learned along the way.